#patients - Techseriesinsight

April 29, 2025
PRNewswire
Healthcare

Free Fitness Classes for Cancer Survivors Return to Petoskey, Presented by Karmanos Cancer Institute and Wayne State University

The Barbara Ann Karmanos Cancer Institute in Detroit is partnering with Wayne State University (WSU) School of Medicine and CrossFit Petoskey to offer cancer survivors 12 weeks of exercise training for free. These classes are...

April 16, 2025
PRNewswire
Biotechnology

28 CAPITAL LAUNCHES NEW VENTURE TO ADVANCE SCIENTIFIC BREAKTHROUGHS FOR PATIENTS

28 Capital, a next-generation life sciences venture capital firm co-founded by biotech entrepreneur John Boyce and venture capitalist Audrey Warner, today announced the launch of its newest platform. Focused on translating cutting-edge...

April 14, 2025
PRNewswire
Biotechnology

Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today...

April 11, 2025
PRNewswire
Healthcare

OrderlyMeds’ Response to Eli Lilly’s Cease-and-Desist Letter

On April 01, 2025, OrderlyMeds received a Cease-and-Desist letter from Eli Lilly regarding the compounding of Tirzepatide. This is our open response. Prescribers and pharmacists have been taking care of...

April 8, 2025
PRNewswire
Healthcare

Dr Crystal Mackall Receives IO360 Lifetime Achievement Award for Pioneering Work in T Cell Therapies

The Conference Forum announced that the Immuno-Oncology 360º (IO360º) Summit honored Crystal Mackall, MD, FAAP, FAACR, Stanford University, with the IO360º Lifetime Achievement Award for her scientific innovation, impact on drug development,...

April 4, 2025
PRNewswire
Biotechnology

Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of Sanjay Keswani, M.D., to the company’s executive management team as Chief Medical Officer (CMO) effective June 2, 2025. Dr. Keswani, an accomplished physician-scientist...

April 4, 2025
PRNewswire
Biotechnology

Lundbeck to present positive pipeline data at American Academy of Neurology (AAN) Annual Meeting

H. Lundbeck A/S (Lundbeck) will present positive interim results from the open-label extension of the PACIFIC trial investigating bexicaserin, in addition to new analyses from clinical trials and real-world...

April 3, 2025
PRNewswire
Healthcare

Lumen Bioscience’s LMN-201 Achieves 100% Initial C. difficile Clinical Cure in Preliminary Cohort of RePreve Trial

In a landmark achievement for its pioneering spirulina-based drug development platform, Lumen announced today top-line results from the sentinel cohort of its RePreve Clinical Trial evaluating LMN-201 for Clostridioides difficile infection (CDI). LMN-201...

April 1, 2025
PRNewswire
Healthcare

ixlayer and Ipsos’ “ixInsights 2025” Study Reveals Consumer Expectations for Digital Health and Pharma’s Role in Enhancing Patient Experience

ixlayer, a leading cloud-based healthtech platform, with Ipsos, a global leader in market research, have released findings from the inaugural research report, “ixlayer ixInsights 2025: Pharma’s Role in Improving the Health...

March 20, 2025
PRNewswire
Biotechnology

Caris Life Sciences Publishes Study Featuring the Largest Real-World Cohort of Tissue-Agnostic Indications Revealing Over 20 Percent of Patients Are Eligible for “Pan-Cancer” Therapies

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced the publication of “Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals” in Nature Communications....